Author

Miroslav Hájek

Czech Academy of SciencesORCID 0000-0002-8906-243XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1

Frequent Co-Authors

Alžběta KadlecováiD· 1 shared Hagen SülzeniD· 1 shared Hanna Tulmin· 1 shared Jaroslav Čermák· 1 shared Jitka Votrubová· 1 shared Martin ZoltneriD· 1 shared Petr PompachiD· 1 shared Sebastian ZolliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alžběta KadlecováORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A selective alternative pathway complement inhibitor for treatment of paroxysmal nocturnal hemoglobinuria

Hagen Sülzen, Hanna Tulmin, Miroslav Hájek, Jaroslav Čermák, Alžběta Kadlecová, Petr Pompach, Jitka Votrubová, Martin Zoltner, Sebastian Zoll

This paper introduces SH-01, a novel recombinant protein that selectively inhibits the complement alternative pathway, showing efficacy in preventing PNH-related erythrocyte lysis and reduced infection risk compared to current treatments.

bioRxiv · Jun 23, 2024 · PreprintImmunology